Claude Cowork is a new computer agent from Anthropic. (Anthropic) If you follow Anthropic, you're probably familiar with Claude Code. Since the fall of 2024, the company has been training its AI ...

A review found that nearly half of the city’s registered rental properties lack occupancy permits. Mayor Applyrs should take assertive action to address that. A Dec. 4 fire at 241 Western Ave. in ...

Microsoft announced that the Copilot Studio extension for the Visual Studio Code (VS Code) integrated development environment is now available to all users. Developers can use it to build and manage ...

Halfway through a decade of post-Covid golf prosperity, the verdict on 2025 is in: Golf design in the United States is strong and getting stronger. Judging by the courses that opened this year, ...

OpenJDK project teams will focus work on features such as value types, code reflection, AOT compilation, and structured concurrency in the coming year. Oracle’s Java team in 2026 will work toward ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Netflix gave Us an early Christmas present by releasing the first Peaky Blinders: The Immortal Man movie trailer. The minute-long clip, which dropped on Wednesday, December 24, opens with a graying ...

Ewan Gleadow is a breaking news reporter for Raw Story based in the United Kingdom. He previously worked for The Daily Mirror and its sister site, The Mirror US. He also runs the music and culture ...

Petter Rudwall knows the idea of AIs becoming sentient and seeking to get high with code-based “drugs” seems “stupid.” But the Swedish creative director couldn’t get it out of his head. Rudwall’s ...

The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...